Blood test may spare heart transplant patients from painful biopsies
NCT ID NCT04707872
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a simple blood test called Prospera can detect heart transplant rejection as accurately as the current standard—a biopsy of the heart. Researchers will compare the blood test results with biopsy results and antibody levels in 300 heart transplant recipients. If the blood test works well, it could one day reduce the need for invasive procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Prospera blood test (donor-derived cell-free DNA)
- What this could lead to
- If successful, this could lead to a simple blood test that reduces the need for invasive heart biopsies to check for transplant rejection.
- What could go wrong
- This is an early-stage study focused on calibrating the test, not proving it works in practice. The blood test may not be accurate enough to replace biopsies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT REJECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Advanced Heart Failure Transplant Unit
NOT_YET_RECRUITINGA Coruña, Spain
-
Annette C. and Harold C. Simmons Transplant Institute, BaylorScott&White Research Institute
RECRUITINGDallas, Texas, 75246, United States
-
Baptist Health Institute for Research and Innovation
RECRUITINGLittle Rock, Arkansas, 72205, United States
-
Cardiac Transplantation Laboratory, The Victor Chang Cardiac Research Institute
NOT_YET_RECRUITINGDarlinghurst, NSW 2010, Australia
-
Cardiovascular Medicine, University of Utah Health
RECRUITINGSalt Lake City, Utah, 84132, United States
-
Columbia University Medical Center, Columbia Interventional Cardiovascular Care
RECRUITINGWest New York, New Jersey, 10032, United States
-
Division of Cardiology, University of Alberta
RECRUITINGEdmonton, Alberta, T6G 2R7, Canada
-
Heart Failure and Heart Transplant Unit, University of Bologna
NOT_YET_RECRUITINGBologna, 40138, Italy
-
Institute for Clinical and Experimental Medicine - IKEM Videnska 1958/9
RECRUITINGPrague, 140 21, Czechia
-
Montefiore Medical Center, 3319 Rochambeau Avenue, 2nd FL
RECRUITINGThe Bronx, New York, 10467, United States
-
Silesian Center for Heart Diseases (Ś!ąskie Centrum Chorób Serca w Zabrzu
RECRUITINGZabrze, 41-800, Poland
-
Tampa General Hospital, 409 Bayshore Blvd.
RECRUITINGTampa, Florida, 33606, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may replace painful heart biopsies for transplant patients
- Heart transplant monitoring may go needle-free with new MRI technique
- Heart transplant warning: could a simple virus test spot rejection early?
- App aims to keep teen heart transplant patients alive and healthy
- New molecular test could spot heart transplant rejection faster
- Scientists hunt for simple blood test to predict heart rejection